With biggest weight loss da­ta in hand, Eli Lil­ly races to start trio of PhI­II tri­als for its ‘triple-G’ can­di­date ...

Last year
R&D
Pharma

For­mer pro soc­cer play­er Rosie White kicks off new Bris­tol My­ers cam­paign for Zeposia in ul­cer­a­tive col­i­tis

Last year
Pharma
Marketing

FDA's top can­cer lead­ers want to shift how com­pan­ion di­ag­nos­tics are reg­u­lat­ed

Last year
FDA+

Mer­ck asks fed­er­al court for sum­ma­ry judg­ment in IRA case

Last year
Pharma
Law

Der­ma­vant taps AI for ‘white-glove’ web­site ser­vice for Vta­ma pso­ri­a­sis med

Last year
AI
Pharma

OTC nasal, ear care prod­uct man­u­fac­tur­er hand­ed a warn­ing let­ter

Last year
Pharma
Manufacturing

How many pa­tients could ben­e­fit from cus­tom ge­net­ic ther­a­pies? Tim­o­thy Yu nar­rows in on an an­swer

Last year
R&D
Cell/Gene Tx

Duke re­ceives $50M FDA award to es­tab­lish new re­search cen­ter

Last year
FDA+

San Diego biotech se­cures $75M to ad­vance lead can­di­date

Last year
Financing

Bris­tol My­ers touts PhI­II Op­di­vo win in urothe­lial car­ci­no­ma; Lim­i­nal Bio­Sciences goes pri­vate

Last year
News Briefing

Tril­lion-dol­lar part­ner: Re­cur­sion rais­es $50M from Nvidia, stock sky­rock­ets

Last year
Financing
AI

Avro­bio ends all de­vel­op­ment, search­es for life af­ter re­cent gene ther­a­py sale to No­var­tis

Last year
People
Cell/Gene Tx

In­cyte says JAK cream clears PhI­II eczema tri­al in chil­dren, but an­a­lysts are still watch­ing safe­ty

Last year
R&D
Pharma

So­ma­Log­ic, co-founder of ac­quired com­pa­ny bat­tle in court over un­vest­ed stock

Last year
Law

Ten­point Ther­a­peu­tics launch­es with $70M to re­store vi­sion with stem cell ther­a­pies and ‘re­pro­gram­ming’ med­i­cines

Last year
Financing
Startups

EU or­ders Il­lu­mi­na to pay $476M fine over un­ap­proved Grail deal

Last year
Deals
Law

Up­dat­ed: FDA to im­port more of com­mon can­cer drug from Chi­na af­ter In­di­an site clo­sure

Last year
China
Pharma

Hu­mi­ra biosim­i­lar launch­es may serve as a test case for wider in­vest­ments, Biosim­i­lars Fo­rum leader cau­tions

Last year
Pharma

Take­da pulls dengue vac­cine ap­pli­ca­tion af­ter FDA re­quests more da­ta

Last year
Pharma
FDA+

Physi­cians see val­ue in con­sumer drug ads, but want more fi­nan­cial and ad­her­ence in­for­ma­tion, sur­vey finds

Last year
Pharma
Marketing

Name that Hu­mi­ra biosim­i­lar: In­side the com­pli­cat­ed process to brand the newest ver­sions of Ab­b­Vie's drug

Last year
Pharma
Marketing

Bris­tol My­ers re­in­forces neu­ro­science deals; Io­vance prices $150M pub­lic of­fer­ing

Last year
News Briefing

ADC Ther­a­peu­tics paus­es Zyn­lon­ta tri­al en­roll­ment af­ter sev­en pa­tient deaths, five se­ri­ous safe­ty events

Last year
R&D

Xspray Phar­ma hand­ed CRL from US reg­u­la­tors seek­ing more in­for­ma­tion about leukemia treat­ment

Last year
FDA+
Manufacturing
First page Previous page 313314315316317318319 Next page Last page
A service from the Financial Times